Glucose and insulin measurements from the oral glucose tolerance test and mortality prediction

Diabetes Care

Volumn 31, Issue 5, 2008, Pages 1026-1030

  Metter, E Jeffrey ^a,c   Windham, B Gwen ^a   Maggio, Marcello ^b   Simonsick, Eleanor M ^a   Ling, Shari M ^a   Egan, Josephine M ^a   Ferrucci, Luigi ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF PARMA   (Italy)

^c HARBOR HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MORTALITY; ORAL GLUCOSE TOLERANCE TEST; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; BLOOD; BLOOD PRESSURE; BODY HEIGHT; BODY SIZE; BODY WEIGHT; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; KINETICS; METABOLISM; MIDDLE AGED; ORAL DRUG ADMINISTRATION; SURVIVAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BODY HEIGHT; BODY SIZE; BODY WEIGHT; DIABETES MELLITUS; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; KINETICS; MALE; MIDDLE AGED; SURVIVAL ANALYSIS;

EID: 48649105817     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc07-2102     Document Type: Article

References (22)

1. Balkau B, Bertrais S, Ducimetiere P, Es- chwege E: Is there a glycemic threshold for mortality risk? Diabetes Care 22:696-699, 1999
2. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R: The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 52:1475-1484, 2003
3. Sorkin JD, Muller DC, Fleg JL, Andres R: The relation of fasting and 2-h postchal- lenge plasma glucose concentrations to mortality: data from the Baltimore Longitudinal Study of Aging with a critical review of the literature. Diabetes Care 28: 2626-2632, 2005
4. The DECODE Study Group: Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 354:617-621, 1999
5. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
6. Lenzen M, Ryden L, Ohrvik J, Bartnik M, Malmberg K, Scholte OP, Reimer W, Simoons, ML: Diabetes known or newlyde- tected, but not impaired glucose regulation, has a negative influence on 1-year outcome in patients with coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart. Eur Heart J 27:2969-2974, 2006
7. Shock NW, Greulich RC, Andres R, Aren- berg D, Costa PT Jr, Lakatta EG, Tobin JD. Normal Human Aging: The Baltimore Longitudinal Study of Aging. Washington, DC, U.S. Govt. Printing Office, 1984 (NIH publ. no. 84-hyphen]2450)
8. Soeldner JS, Slone D: Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes 14:771-779, 1965
9. Muller DC, Elahi D, Tobin JD, Andres R: Insulin response during the oral glucose tolerance test: the role of age, sex, body fat and the pattern of fat distribution. Aging (Milano) 8:13-21, 1996
10. Van Buuren S, Oudshoorn CGM: Multi- variate imputation by chained equations: MICE V1.0 User's Manual. Leiden, TNO Preventie en Gezondheid, 2000 (Report PG/VGZ/00.038)
11. Wallace TM, Matthews DR: The assessment of insulin resistance in man. Diabet Med 19:527-534, 2002
12. Therneau TM, Grambsch PM: Modeling survival data extending the Cox model. New York, Springer, 2000
13. Hoeting JA, Madigan D, Raftery AE, Vo- linsky CT: Bayesian model averaging: a tutorial. Stat Sci 14:382-417, 1999
14. Wild SH, Smith FB, Lee AJ, Fowkes FG: Criteria for previously undiagnosed diabetes and risk of mortality: 15-year follow-up of the Edinburgh Artery Study cohort. Diabet Med 22:490-496, 2005
15. Seeman TE, Robbins RJ: Aging and hypo- thalamic-pituitary-adrenal response to challenge in humans. Endocr Rev 15:233-260, 1994
16. Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM: Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study of Aging. Diabetes 53:2095-2100, 2004
17. Harman SM, Metter EJ, Tobin JD, Pearson J, Blackman, MR: Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metabol 86:724-731, 2001
18. Rowe JW, Andres R, TobinJD, Norris AH, Shock NW: The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol 31:155-163, 1976
19. Tschritter O, Fritsche A, Shirkavand F, Machicao F, Haring H, Stumvoll M: Assessing the shape of the glucose curve during an oral glucose tolerance test. Diabetes Care 26:1026-1033, 2003
20. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Jarvinen, Van Haeften T, Renn W, Gerich J: Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23:295-301, 2000
21. Matsuda M, DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the eu- glycemic insulin clamp. Diabetes Care 22: 1462-1470, 1999
22. Mari A, Pacini G, Murphy E, Ludvik B, Nolan JJ: A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care 24: 539-548, 2001